TAVI平台和外科动脉置换的比较有效性:随机对照试验的网络元分析
Francesco Moroni1, Pablo Lamelas2,3, Ariel Izcovich4
1Division of Cardiology, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.M.).
Circulation. Cardiovascular interventions
|September 11, 2025
概括
过导管大动脉植入器 (TAVI) 装置的有效性各不相同. 核心-进化TAVI与手术大动脉置换 (SAVR) 的死亡率相似,而SAPIEN和ACURATE新型TAVI增加了死亡风险.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 生物材料科学 生物材料科学
背景情况:
- 临床指导方针经常假定跨导管大动脉植入装置 (TAVI) 的效果相似,这表明一个类效应.
- 这种假设需要对不同TAVI平台进行严格的比较有效性研究.
研究的目的:
- 评估各种TAVI器件彼此之间的比较有效性,以及对外科大动脉置换 (SAVR) 的比较有效性.
- 评估以患者为中心的结果,包括全因死亡率,心血管死亡率和中风.
主要方法:
- 在MEDLINE,Embase和CENTRAL进行了随机对照试验 (RCT) 的系统文献搜索,直到2025年4月.
- 使用频率网络元分析来估计治疗效果,使用推,评估,开发和评估 (GRADE) 方法评估证据确定性.
主要成果:
- 涉及9946名参与者的11个RCT显示,使用CoreValve-Evolut的TAVI与SAVR的死亡率相似.
- 与SAVR和CoreValve-Evolut相比,TAVI与SAPIEN和ACURATEneo显示所有原因和心血管死亡率增加.
- 所有的TAVI平台与SAVR相比,都与更高的再干预和心脏起器植入率有关.
结论:
- 在CoreValve-Evolut TAVI装置中,死亡率似乎与SAVR相似.
- 与SAVR和CoreValve-Evolut相比,SAPIEN和ACURATE新型TAVI设备与死亡风险的增加有关.
- 来自RCT的证据驳斥了TAVI门具有普遍类效应的假设.
相关概念视频
Aortic Regurgitation III: Medical Management
401
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
401
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
420
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
420
Mitral Stenosis III: Medical Management
249
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
249
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Mitral Valve Prolapse II: Assessment and Management
445
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
445
Aortic Regurgitation I: Introduction
504
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
504


